• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-362-5p 作为细胞遗传学正常的急性髓系白血病的新型预后预测因子。

MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.

机构信息

Department of Hematology, The First Affiliated Hospital, Zhejiang University of Medicine, No. 79 Qingchun Road, 310003, Hangzhou, Zhejiang, People's Republic of China.

Key Laboratory of Hematopoietic Malignancies, Hangzhou, Zhejiang Province, People's Republic of China.

出版信息

J Transl Med. 2018 Mar 14;16(1):68. doi: 10.1186/s12967-018-1445-3.

DOI:10.1186/s12967-018-1445-3
PMID:29540187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853092/
Abstract

BACKGROUND

MicroRNAs are of special interest in cancer research and hold significant promise as diagnostic and prognostic biomarkers for malignant disease. MiR-362-5p have been found to exert both oncogenic and tumor suppressive effects depending highly on the cellular context. The aim of this study was to determine whether the expression of miR-362-5p can be served as a prognostic factor for patients with cytogentically normal acute myeloid leukemia (CN-AML).

METHODS

We enrolled 224 patients with CN-AML and measured the expression of miR-362-5p by quantitative real time PCR analysis. We classified patients into high and low expression based on the median value. The Cox regression analyses were carried out to assess the prognostic significance of miR-362-5p expression in the context of the well-established predictors. Additionally, microRNA expression profiling were conducted to identify the biological insights between high and low group.

RESULTS

High expressers had older age. High expressers obtained shorter overall survival in the univariate analysis. The independent prognostic value of miR-362-5p remained in the context of the well-established clinical and cytogenetic predictors. Moreover, the prognostic value of miR-362-5p was also validated in an independent cohort of CN-AML. Notably, numerous oncomiRs were also high expressed in high miR-362-5p group.

CONCLUSION

High miR-362-5p expression was associated with poorer overall survival implicating the oncogenic function in AML development.

摘要

背景

microRNAs 在癌症研究中备受关注,作为恶性疾病的诊断和预后生物标志物具有重要意义。miR-362-5p 的作用具有癌基因和肿瘤抑制作用,这高度依赖于细胞环境。本研究旨在确定 miR-362-5p 的表达是否可以作为细胞遗传学正常急性髓系白血病(CN-AML)患者的预后因素。

方法

我们招募了 224 名 CN-AML 患者,并通过定量实时 PCR 分析测量了 miR-362-5p 的表达。我们根据中位数将患者分为高表达和低表达。Cox 回归分析用于评估 miR-362-5p 在既定预测因子背景下的预后意义。此外,还进行了 microRNA 表达谱分析,以确定高表达和低表达组之间的生物学见解。

结果

高表达者年龄较大。在单因素分析中,高表达者的总生存率较短。miR-362-5p 的独立预后价值在既定的临床和细胞遗传学预测因子背景下仍然存在。此外,miR-362-5p 的预后价值也在 CN-AML 的独立队列中得到验证。值得注意的是,在高 miR-362-5p 组中,许多癌基因也高表达。

结论

高 miR-362-5p 表达与总体生存率较差相关,提示其在 AML 发展中具有致癌功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/5853092/0ee318d8efc2/12967_2018_1445_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/5853092/818b2eaecf7b/12967_2018_1445_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/5853092/0ee318d8efc2/12967_2018_1445_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/5853092/818b2eaecf7b/12967_2018_1445_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/5853092/0ee318d8efc2/12967_2018_1445_Fig2_HTML.jpg

相似文献

1
MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.miR-362-5p 作为细胞遗传学正常的急性髓系白血病的新型预后预测因子。
J Transl Med. 2018 Mar 14;16(1):68. doi: 10.1186/s12967-018-1445-3.
2
Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.鉴定let-7a-2-3p或/和miR-188-5p作为细胞遗传学正常的急性髓系白血病的预后生物标志物。
PLoS One. 2015 Feb 3;10(2):e0118099. doi: 10.1371/journal.pone.0118099. eCollection 2015.
3
High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.TET1 高表达预示着两个队列中细胞遗传学正常的急性髓系白血病患者的生存预后不良。
EBioMedicine. 2018 Feb;28:90-96. doi: 10.1016/j.ebiom.2018.01.031. Epub 2018 Jan 31.
4
Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.血清 miR-34a 作为急性髓系白血病潜在生物标志物的鉴定。
Cancer Biomark. 2018;22(4):799-805. doi: 10.3233/CBM-181381.
5
Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia.血浆外泌体来源的 microRNA-532 作为急性髓系白血病的新型预测因子。
Cancer Biomark. 2020;28(2):151-158. doi: 10.3233/CBM-191164.
6
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.BAALC相关微小RNA miR-3151的表达水平是年轻的细胞遗传学中危急性髓系白血病患者的独立预后因素。
Blood Cancer J. 2015 Oct 2;5(10):e352. doi: 10.1038/bcj.2015.76.
7
High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.骨髓中miR-19b水平升高预示初发急性髓系白血病预后不良及疾病复发。
Gene. 2018 Jan 15;640:79-85. doi: 10.1016/j.gene.2017.10.034. Epub 2017 Oct 12.
8
Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.miR-216b 过表达:在急性髓系白血病中的预后和预测价值。
J Cell Physiol. 2018 Apr;233(4):3274-3281. doi: 10.1002/jcp.26171. Epub 2017 Sep 28.
9
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.内源性肿瘤抑制 microRNA-193b 在急性髓系白血病中的治疗和预后价值。
J Clin Oncol. 2018 Apr 1;36(10):1007-1016. doi: 10.1200/JCO.2017.75.2204. Epub 2018 Feb 12.
10
High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.2型肌醇1,4,5-三磷酸受体(ITPR2)高表达作为细胞遗传学正常的急性髓系白血病预后较差的一种新型生物标志物。
Oncotarget. 2015 Mar 10;6(7):5299-309. doi: 10.18632/oncotarget.3024.

引用本文的文献

1
Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia.非编码RNA在急性髓系白血病中的功能、机制及治疗意义
Fundam Res. 2023 May 16;5(4):1781-1794. doi: 10.1016/j.fmre.2023.04.012. eCollection 2025 Jul.
2
induced miR-362-5p upregulation drives gastric cancer progression and links hepatocellular carcinoma through an exosome-dependent pathway.诱导的miR-362-5p上调通过外泌体依赖途径驱动胃癌进展并与肝细胞癌相关联。
Front Cell Infect Microbiol. 2025 May 8;15:1582131. doi: 10.3389/fcimb.2025.1582131. eCollection 2025.
3
A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia.

本文引用的文献

1
Role of microRNAs in translation regulation and cancer.微小RNA在翻译调控及癌症中的作用
World J Biol Chem. 2017 Feb 26;8(1):45-56. doi: 10.4331/wjbc.v8.i1.45.
2
MicroRNAs as prognostic biomarker and relapse indicator in leukemia.微小RNA作为白血病的预后生物标志物和复发指标
Clin Transl Oncol. 2017 Aug;19(8):951-960. doi: 10.1007/s12094-017-1638-x. Epub 2017 Mar 7.
3
lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.用于急性髓系白血病预后分析的长链非编码RNA共表达网络模型
一种用于改善细胞遗传学正常的急性髓系白血病风险分层的新型5基因预后特征。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10015-10025. doi: 10.1007/s00432-023-04884-y. Epub 2023 Jun 1.
4
Research progress on molecular biomarkers of acute myeloid leukemia.急性髓系白血病分子生物标志物的研究进展
Front Oncol. 2023 Feb 7;13:1078556. doi: 10.3389/fonc.2023.1078556. eCollection 2023.
5
The Promising Role of Non-Coding RNAs as Biomarkers and Therapeutic Targets for Leukemia.非编码 RNA 作为白血病生物标志物和治疗靶点的研究进展
Genes (Basel). 2023 Jan 3;14(1):131. doi: 10.3390/genes14010131.
6
Identification of circRNA-miRNA-Immune-Related mRNA Regulatory Network in Gastric Cancer.胃癌中环状RNA-微小RNA-免疫相关信使核糖核酸调控网络的鉴定
Front Oncol. 2022 Feb 24;12:816884. doi: 10.3389/fonc.2022.816884. eCollection 2022.
7
MicroRNA-362-5p promotes the proliferation and inhibits apoptosis of trophoblast cells via targeting glutathione-disulfide reductase.miRNA-362-5p 通过靶向谷胱甘肽二硫化物还原酶促进滋养细胞的增殖并抑制其凋亡。
Bioengineered. 2021 Dec;12(1):2410-2419. doi: 10.1080/21655979.2021.1933678.
8
miR-4792 Inhibits Acute Myeloid Leukemia Cell Proliferation and Invasion and Promotes Cell Apoptosis by Targeting Kindlin-3.miR-4792 通过靶向 Kindlin-3 抑制急性髓系白血病细胞增殖、侵袭并促进细胞凋亡。
Oncol Res. 2020 Sep 1;28(4):357-369. doi: 10.3727/096504020X15844389264424. Epub 2020 Mar 17.
9
Comparing MicroRNA Profilings of Purified HER-2-Negative and HER-2-Positive Cells Validates miR-362-5p/Sema3A as Characteristic Molecular Change in Triple-Negative Breast Cancers.比较 HER-2 阴性和 HER-2 阳性细胞的 MicroRNA 图谱,验证 miR-362-5p/Sema3A 是三阴性乳腺癌的特征性分子变化。
Dis Markers. 2019 Dec 16;2019:6057280. doi: 10.1155/2019/6057280. eCollection 2019.
10
EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia.EZH2 失调:预测急性髓系白血病预后和指导治疗选择的潜在生物标志物。
J Cell Mol Med. 2020 Jan;24(2):1640-1649. doi: 10.1111/jcmm.14855. Epub 2019 Dec 3.
Int J Mol Med. 2017 Mar;39(3):663-671. doi: 10.3892/ijmm.2017.2888. Epub 2017 Feb 13.
4
MicroRNA: Defining a new niche in Leukemia.微小RNA:在白血病中定义一个新的生态位。
Blood Rev. 2017 May;31(3):129-138. doi: 10.1016/j.blre.2016.11.003. Epub 2016 Nov 24.
5
Molecular biomarkers in acute myeloid leukemia.急性髓系白血病中的分子生物标志物
Blood Rev. 2017 Jan;31(1):63-76. doi: 10.1016/j.blre.2016.08.005. Epub 2016 Sep 2.
6
miR-126 Drives Quiescence and Self-Renewal in Leukemic Stem Cells.miR-126 驱动白血病干细胞的静止和自我更新。
Cancer Cell. 2016 Feb 8;29(2):133-5. doi: 10.1016/j.ccell.2016.01.007.
7
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.微小RNA-126调控正常和恶性造血干细胞中不同的自我更新结果。
Cancer Cell. 2016 Feb 8;29(2):214-28. doi: 10.1016/j.ccell.2015.12.011. Epub 2016 Jan 28.
8
Dysregulation of microRNA biogenesis machinery in cancer.癌症中微小RNA生物合成机制的失调。
Crit Rev Biochem Mol Biol. 2016 May-Jun;51(3):121-34. doi: 10.3109/10409238.2015.1117054. Epub 2015 Dec 1.
9
miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway.微小RNA-125a通过抑制PI3K/AKT/mTOR信号通路来抑制肝癌细胞的迁移和侵袭。
Oncol Lett. 2015 Aug;10(2):681-686. doi: 10.3892/ol.2015.3264. Epub 2015 May 26.
10
MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α.微小RNA-362-5p通过下调生长停滞和DNA损伤诱导蛋白45α促进慢性髓细胞白血病的恶性发展。
Mol Cancer. 2015 Nov 6;14:190. doi: 10.1186/s12943-015-0465-3.